Viraferonpeg 120mcg Injection

Visão geral do produto

About Viraferonpeg 120mcg Injection

Viraferonpeg 120mcg Injection is a prescription medicine containing pegylated interferon alpha 2B. It is formulated as a sterile solution for subcutaneous injection. The product is intended for use under the supervision of a qualified healthcare professional. Each vial contains 120 micrograms of the active ingredient in a clear, colorless liquid. The medication is supplied in single-use prefilled syringes to ensure accurate dosing and sterility. The formulation is stable at refrigerated temperatures and should be protected from light. Viraferonpeg 120mcg Injection is used in the treatment of chronic viral infections and certain autoimmune conditions. It is not intended for self‑administration without medical guidance. The product is manufactured in accordance with Good Manufacturing Practice regulations and is subject to routine quality control testing. Patients should follow the dosing schedule prescribed by their clinician and report any adverse reactions promptly.

Key Benefits & Uses

• Provides antiviral activity against hepatitis B and C viruses.
• Helps modulate the immune response in autoimmune disorders.
• Offers a convenient dosing schedule with once‑weekly injections.

Active Ingredient & Action

The active ingredient, pegylated interferon alpha 2B, is a modified form of interferon that has a polyethylene glycol (PEG) chain attached. This modification extends the drug’s half‑life, allowing for less frequent dosing. Interferon alpha 2B works by stimulating the immune system to recognize and destroy infected cells. It also interferes with viral replication and enhances the antiviral state of surrounding tissues. The pegylation process reduces the frequency of side‑effects related to rapid clearance and improves patient compliance.

Important Notes

Viraferonpeg 120mcg Injection should be stored refrigerated and kept out of direct sunlight. Do not freeze the product. Patients should receive a thorough medical evaluation before starting therapy, and regular monitoring of blood counts and liver function is recommended. Report any signs of infection, fever, or unusual fatigue to a healthcare provider immediately. The medication is contraindicated in patients with severe liver disease or uncontrolled thyroid disorders. Follow all instructions provided by your prescribing clinician and the product’s patient information leaflet.